
Zoetis Inc. (ZTS)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutZoetis delivered a better-than-expected adjusted EPS of $1.75, but revenue declined and U.S. companion-animal demand remained weak. Livestock and diagnostics growth partly offset dermatology pressure, while management raised adjusted earnings guidance but expects competitive and clinic-traffic challenges to continue into 2027.[3][4] The most recent completed trading session, November 6, ended down 3.24%, including regular-session and after-hours trading.










